Ibnsina Pharma’s consolidated profits sink 45.16% YoY in 2022: Egypt

Ibnsina Pharma (ISPH) reported a 45.16% year-on-year (YoY) decrease in its consolidated net profits after tax and non-controlling interests for the full year ended December 31st, 2022, according to the company’s financial statements filed to the Egyptian Exchange (EGX) on March 1st.

The company’s consolidated net profit after minority interest stood at EGP 172.584 million in 2022, down from EGP 314.727 million in 2021.